Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children With Juvenile Myelomonocytic Leukemia (JMML)

NCT01824693 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01824693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01824693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children With Juvenile Myelomonocytic Leukemia (JMML)
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
June 24, 2013
Completion date
December 31, 2017
Enrollment
30 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile myelomonocytic leukemia